Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00269425 · ClinicalTrials.gov registry record · Phase 3

The Heart Institute of Spokane Diet Study

A Phase 3 study, sponsored by Providence Health & Services.

Completed
Registry status
Phase 3
Development phase
202
Enrollment target

NCT00269425: Completed Phase 3 study, sponsored by Providence Health & Services.

NCT00269425 is a Phase 3 study that has completed, run by Providence Health & Services. The registered enrollment target is 202 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00269425, a Phase 3 study, has completed, sponsored by Providence Health & Services.

COMPLETED
Registry status
Phase 3
Development phase
202 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether a Mediterranean style diet, enriched in monounsaturated and omega-3 fats, is superior to the American Heart Association Step 2 diet, a traditional low fat diet, for improving rates of survival and cardiovascular complications in persons who have had a first myocardial infarction (heart attack).

Primary Outcome

The primary outcome was a composite of end points including all-cause and cardiac deaths, MI, hospital admissions for heart failure, unstable angina, or stroke.

Interventions

  • BEHAVIORAL Mediterranean diet
  • BEHAVIORAL American Heart Association Step 2 diet

Trial Details

FieldValue
Enrollment Target 202 participants
Start Date 2000-10
Est. Completion 2008-01
Phase Phase 3
Providence Health & Services

69 total trials

What the finished NCT00269425 record still lists

NCT00269425 is an interventional study that assigns participants to a tested intervention. The registered 202 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).

The record links to 0 conditions, and to 2 interventions - of which Mediterranean diet is the first listed.

NCT00269425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00269425 about?

NCT00269425 is a clinical study titled "The Heart Institute of Spokane Diet Study". The purpose of this study is to determine whether a Mediterranean style diet, enriched in monounsaturated and omega-3 fats, is superior to the American Heart Association Step 2 diet, a traditional low fat diet, for improving rates of survival and cardiovascular complications in persons who have had ...

What is the current status of trial NCT00269425?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 202 participants. The study started on 2000-10. Estimated completion is 2008-01.

What interventions are being tested in trial NCT00269425?

The interventions under investigation include: Mediterranean diet (BEHAVIORAL), American Heart Association Step 2 diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT00269425?

This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00269425's enrollment target sits among peer trials

202 1353rd of 2000 higher than 648 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05272254 · 202 participants · Phase 2

    Povidone Iodine Efficacy Study

  • NCT05701280 · 202 participants · NA

    Pilot/Pivotal Study of DBS+Rehab After Stroke

  • NCT05932589 · 202 participants

    Neurophysiologic Biomarkers in Rett Syndrome

  • NCT06014931 · 202 participants · NA

    Telehealth-enhanced Patient-oriented Recovery Trajectory After Intensive Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00269425, the US trial registry maintained by the National Library of Medicine. NCT00269425 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.